MedTrace Logo

PPCM Observational Study (Peripartum Cardiomyopathy)

NCT04234659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-02-23

No results posted yet for this study

Summary

The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.

Conditions

  • Peripartum Cardiomyopathy
  • Cardiogenic Shock

Interventions

DEVICE

Clinical placement of a temporary IMPELLA® mechanical circulatory support device.

Surgical placement of the IMPELLA® device for life threatening cardiogenic shock not responsive to other medical treatment.

Sponsors & Collaborators

Principal Investigators

  • Sarah Thordsen, MD · Medical College of Wisconsin

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-11
Primary Completion
2025-08-05
Completion
2025-08-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04234659 on ClinicalTrials.gov